Venus Remedies, a Rs 200 crore plus pharma company, has received the European GMP accreditation for its oncology manufacturing facilities.
The company received approval for both oncology manufacturing facilities as well as oncology liquid and lyophilized facilities. Thus Venus has cleared the prerequisite for export to European Union with this EU GMP and can now actively approach multinational companies in EU, which includes 36 countries, as well as in Canada and Australia for site transfer projects for its range of oncology products.
The oncology liquid injection and lyophilized injection plants of the company were inspected by the European authorities in May this year and found to be complying with the manufacturing and quality control standards as per the European Good Manufacturing Practice, a company release said.
The company already has strategic tie-ups for product development, manufacturing and marketing with two of the leading MNCs from Europe for site transfer of oncology products to Venus India, for sales in EU.